Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
46.6M
-
Shares change
-
+585K
-
Total reported value, excl. options
-
$6.15B
-
Value change
-
+$72.9M
-
Put/Call ratio
-
0.94
-
Number of buys
-
95
-
Number of sells
-
-73
-
Price
-
$132.00
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q1 2019
227 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q1 2019.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.6M shares
of 1.39B outstanding shares and own 3.36% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (12M shares), FMR LLC (5.61M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (4.44M shares), WELLINGTON MANAGEMENT GROUP LLP (2.65M shares), Temasek Holdings (Private) Ltd (2.27M shares), BlackRock Inc. (1.92M shares), VANGUARD GROUP INC (1.24M shares), CANADA PENSION PLAN INVESTMENT BOARD (1.16M shares), HILLHOUSE CAPITAL MANAGEMENT, LTD. (1.03M shares), and PRIMECAP MANAGEMENT CO/CA/ (920K shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.